C-MER Medical Holdings Limited (Stock Code: 03309) disclosed a Next Day Disclosure Return, indicating a repurchase of 200,000 shares on 21 October 2025, to be held as treasury shares. The repurchase price averaged around HKD 1.9065 per share.

According to the announcement, the total number of issued shares of C-MER Medical, excluding treasury shares, stood at 1,242,576,870 as of 21 October 2025, while treasury shares increased to 12,984,000. The closing balance of the company’s total issued shares (including treasury shares) therefore remained at 1,255,560,870.

Additionally, the announcement listed earlier repurchases, scheduled for cancellation but not yet canceled, carried out from July 2024 to May 2025. Those repurchases involved various transaction dates and share quantities at different prices. As of the date submitted, no material changes have been noted beyond the disclosed details, and the company confirmed compliance with relevant share repurchase rules.